Poster

A novel mathematical framework to predict in vivo bispecific GTX-B001 binding in skin, and translation to humans

See how quantitative pharmacology and PBPK modeling supported first in human dose selection for a…

Certara2026 年 7 月 20 日

Conference

EANM 2026

–

Danielle Pillsbury2026 年 7 月 20 日

Webinar

From Dosimetry to Dose Decisions How Clinical Pharmacology and Model-Informed Approaches Are Shaping TRT Development

Hunter Stephens, PhD2026 年 7 月 17 日

Blog

Model smarter, not harder: how Phoenix Cloud puts the science back at the center of modeling

Certara Model Designer brings cloud based pharmacometric modeling to your browser, with a curated model…

Arjen Bos2026 年 7 月 16 日

Publication

Current State-of-the-Art and Future Advancements of Model-Based Meta-Analysis

Explore how model-based meta-analysis supports dose optimization, trial design, and regulatory decisions, plus emerging roles…

Certara2026 年 7 月 16 日

Blog

When to Conduct Hepatic Impairment Studies and When Modeling May be Enough

How to decide if a hepatic impairment study is required, choose the right study design,…

Certara2026 年 7 月 13 日

Conference

ASA Biopharmaceutical Section Regulatory-Industry Statistics Workshop

Certara2026 年 7 月 9 日

Webinar

Integrated mechanistic modeling approaches in oncology drug development

Certara2026 年 7 月 8 日

Blog

Dosimetry for Radiopharmaceutical Therapy: From Measurement to Dose Justification

Why dosimetry for radiopharmaceutical therapy needs more than absorbed dose. How BED, radiation dosimetry &…

Hunter Stephens, PhD2026 年 7 月 7 日

On-Demand Webinar

The Power of Modeling: Speed, Early De-Risking, and Regulatory Success for Forward-Thinking Sponsors

Learn how PBPK and QSP modeling support faster drug development by enabling smarter dose selection,…

Certara2026 年 7 月 1 日

沪ICP备2022021526号

Powered by Translations.com GlobalLink Web Software

模型引导的药物开发

A novel mathematical framework to predict in vivo bispecific GTX-B001 binding in skin, and translation to humans

EANM 2026

From Dosimetry to Dose Decisions How Clinical Pharmacology and Model-Informed Approaches Are Shaping TRT Development

Model smarter, not harder: how Phoenix Cloud puts the science back at the center of modeling

Current State-of-the-Art and Future Advancements of Model-Based Meta-Analysis

When to Conduct Hepatic Impairment Studies and When Modeling May be Enough

ASA Biopharmaceutical Section Regulatory-Industry Statistics Workshop

Integrated mechanistic modeling approaches in oncology drug development

Dosimetry for Radiopharmaceutical Therapy: From Measurement to Dose Justification

The Power of Modeling: Speed, Early De-Risking, and Regulatory Success for Forward-Thinking Sponsors

订阅时事通讯

快捷链接

解决方案

联系我们